Product Categories
| Country: | United States |
|---|---|
| Tel: | +86-0714-3992388 |
| Mobile: | +86-15391658522 |
| E-mail: | overseasales@yongstandards.com |
| QQ: | 2853117752 |
| Skype: | Chat Now! |
| Address: | No.176,Hangzhou West Road, Xialu Area, Huangshi |
|
China National Standard Pharmaceutical Corporation Limited is a strict standard company. Its main members are former senior employees from EDQM and The United States Pharmacopeial Convention. Standardpharm Co., Ltd. work together with Standardpharm CHN Co., Ltd. to serve scientists in the field of generic pharmaceuticals and innovative pharmaceuticals worldwide.
Standardpharm Co., Ltd. is a professional company specializing in the custom synthesis of pharmaceutical reference standards for biomedical and pharmaceutical research. We supply reference standards worldwide to clients base that includes major biotechnology corporations, pharmaceutical and diagnostic companies, clinical and bio-analytical CROs, manufacturers of specialty chemicals, as well as hospital researchers, universities and various other research institutions, including EDQM, USP, BP, JP, CHP, and Pfizer, TEVA, etc.
Standardpharm has over 600,000 products in 10 application area, including: Pharmaceutical Impurities, Pesticide and Veterinary Pharmaceutical Residues, Isotopes, Essence and Pigment, Criminal Justice Medicine, Natural pharmaceutical Extraction, Cosmetic, Environmental Protection, Food safety, Industrial Auxiliary Materials. Certificate of Analysis (COA) will be provided for all these products which characterized using HPLC/GC, MS, HNMR, synthetic route, spectrum analysis and other testing (CNMR, FNMR, COSY, NOESY, DEPT, HMBC, HMQC, HSQC, IR, UV, QNMR, TGA, elemental analysis, etc. ) as requested spectra by our clients. And STD Promises to return or exchange the goods to solve the problem as quickly as possible if any quality problem is found within the contractual period. STD has inventory in both China and the United States to ensure the fastest delivery for customers.
Welcome to consult us by email in any time.
|
|
| Product Name | MF | CAS | Details |
|---|
| Pazopanib Impurity 28 | C4H3ClN2O | 55873-09-1 | Details |
| Pazopanib Impurity 22 | C14H14ClN5 | 444731-75-3 | Details |
| Parecoxib Impurity 15 | C16H12ClNO3S | 509074-26-4 | Details |
| Parecoxib Impurity 8 | C18H16N2O4S | 198471-06-6 | Details |
| Parecoxib Impurity 27 | C20H20N2O4S | 198470-82-5 | Details |
| Paracetamol Impurity 1（Paracetamol EP Impurity A） | C8H9NO2 | 614-80-2 | Details |
| Parecoxib Impurity 65 | C19H18N2O4S | 2304623-38-7 | Details |
| Palonosetron Impurity 22 | C18H26N2 | 1251515-96-4 | Details |
| Paracetamol Impurity 21 | C16H16N2O4 | 98966-17-7 | Details |
| Parecoxib Impurity 55 | C16H12ClNO3S | 1037546-03-4 | Details |
| Palonosetron Impurity 24 | C11H12O2 | 83721-32-8 | Details |
| Pazopanib Impurity 4 | Details |
| Pazopanib Impurity 2 | C21H24ClN7O2S | 2518115-74-5 | Details |
| Parecoxib Impurity 56 | C16H12ClNO3S | 2304623-42-3 | Details |
| Parecoxib Impurity 41 | C16H15N3O5S2 | 2455497-80-8 | Details |
| Paracetamol Impurity 30 (Paracetamol EP Impurity O) | C16H16N2O4 | 2575516-61-7 | Details |
| Parecoxib Impurity 12 | C16H15NO2 | 181696-73-1 | Details |
| Paracetamol Impurity 2（Paracetamol EP Impurity B） | C9H11NO2 | 1693-37-4 | Details |
| Parecoxib Impurity 95 | C14H13NO | 26306-06-9 | Details |
| Parecoxib Impurity 26 | C32H25N3O6S2 | 1373038-60-8 | Details |
| Parecoxib Impurity 2 | C16H15N3O5S2 | 1373038-59-5 | Details |
| Parecoxib Impurity 1 | C16H14N2O3S | 1373038-56-2 | Details |
| Pazopanib Impurity 13 | C26H23ClN10 | 1226500-02-2 | Details |
| Pazopanib Impurity 11 | C14H14ClN5 | 1252927-45-9 | Details |
| Pazopanib Impurity 23 | C15H17N5O | 1296888-47-5 | Details |
| Parecoxib Impurity 61 | C6H6ClN3O2S | 35282-78-1 | Details |
| Parecoxib Impurity 40 | C16H15N3O5S2 | 2251048-58-3 | Details |
| Paracetamol Impurity 50 | C15H23NO2 | 101-95-1 | Details |
| Palonosetron Impurity 25 | C18H24N2O | 135729-78-1 | Details |
| Panobinostat Impurity 2 | C20H23BN2O4S | 1185427-23-9 | Details |
| Parecoxib Impurity 31 | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
| Parecoxib Impurity 38 | C16H13NO | 75115-00-3 | Details |
| Parecoxib Impurity 21 | C18H17NO4S | 1884279-18-8 | Details |
| Palonosetron Impurity 23 | C15H20N2 | 120570-06-1 | Details |
| Parecoxib Impurity 85 | C16H14O3 | 36374-51-3 | Details |
| Parecoxib Impurity 35 | C16H15N3O5S2 | 2616621-78-2 | Details |
| Paracetamol Impurity 7（Paracetamol EP Impurity G） | C8H9NO2 | 34523-34-7 | Details |
| Palonosetron Impurity 2 (Palonosetron (S,R)-Isomer) (Palonosetron USP Related Compound C) | C19H25ClN2O | 135729-76-9 | Details |
| Paracetamol Impurity 44 | C9H10N2O4 | 50651-39-3 | Details |
| Pazopanib Impurity 17 | C9H11N3 | 221681-92-1 | Details |
| Parecoxib Impurity 83 | C16H14O3 | 108837-08-7 | Details |
| Palonosetron Impurity 20 | C18H26N2 | 2216746-63-1 | Details |
| Parecoxib Impurity 46 | C19H18N2O4S | 477594-28-8 | Details |
| Paracetamol Impurity 10（Paracetamol EP Impurity J） | C8H8ClNO | 539-03-7 | Details |
| Pazopanib Impurity 39 | C9H11N3 | 1783625-55-7 | Details |
| Palonosetron Impurity 21 | C18H26N2 | 2216755-70-1 | Details |
| Palonosetron Impurity 3 (Palonosetron (R,R)-Isomer)(Palonosetron Enantiomer) | C19H24N2O | 135729-75-8 | Details |
| Paracetamol Impurity 19-d3 | C8H8KNO5S | 1188263-45-7 | Details |
| Pazopanib Impurity 21 | C9H12ClN3 | 635702-60-2 | Details |
| Parecoxib Impurity 25 | C16H13NO4S | 181696-35-5 | Details |
| Parecoxib Impurity 64 | C16H14N2O3S | 2304623-36-5 | Details |
| Parecoxib Impurity 34 | C16H12ClNO3S | 1373038-57-3 | Details |
| Palonosetron Impurity 40 | C19H24N2O2 | 848074-08-8 | Details |
| Pazopanib Impurity 14 | C27H25ClN10 | 1252927-44-8 | Details |
| Parecoxib Impurity 24 | C19H18N2O4S | 1709956-89-7 | Details |
| Paracetamol Impurity 29 | C8H7NO3 | 121-89-1 | Details |
| Parecoxib Impurity 52 | C20H20N2O4S | 198470-91-6 | Details |
| Parecoxib Impurity 36 | C16H14N2O3S | 2304623-35-4 | Details |
| Paracetamol Impurity 35 | C14H13N2O8P | 905-14-6 | Details |
| Parecoxib Impurity 77 | C19H18N2O4S | 2242749-02-4 | Details |
| Parecoxib Impurity 7 | C16H14N2O3S | 181695-72-7 | Details |
| Parecoxib Impurity 9 | C16H13NO | 37928-17-9 | Details |
| Parecoxib Impurity 49 | C16H12ClNO | 1448355-87-0 | Details |
| Parecoxib Impurity 39 | C32H24N2O4S | 2338845-31-9 | Details |
| Parecoxib Impurity 47 | C22H23N3O7S2 | 2860553-54-2 | Details |
| Pazopanib Impurity 18 | C7H8N2O4S | 6269-91-6 | Details |
| Palonosetron Impurity 39 | C19H24N2O2 | 176019-33-3 | Details |
| Parecoxib Impurity 32 | C16H14N2O3S | 181696-12-8 | Details |
| Parecoxib Impurity 78 | C19H18N2O5S | 198471-83-9 | Details |
| Papaverine Impurity 2 (Papaverine EP Impurity B) | C20H21NO5 | 482-76-8 | Details |
| Papaverine Impurity 4 (Papaverine EP Impurity D) | C20H19NO5 | 522-57-6 | Details |
| Parecoxib Impurity 33 | C16H12ClNO3S | 1709956-95-5 | Details |
| Parecoxib Impurity 81 | C22H18O2 | 71189-82-7 | Details |
| Paracetamol Impurity 15（Acetaminophen Dimer） | C16H16N2O4 | 98966-14-4 | Details |
| Paracetamol Impurity 5（Paracetamol EP Impurity E） | C8H8O2 | 99-93-4 | Details |
| Pazopanib Impurity 30 | C10H13N3 | 1376676-65-1 | Details |
| Parecoxib Impurity 42 | C18H18N2O3S | 473465-11-1 | Details |
| Pazopanib Impurity 25 | C8H10N2O2 | 90007-09-3 | Details |
| Pazopanib Impurity 12 | C4H3ClN2O | 80927-55-5 | Details |
| Pazopanib Impurity 19 | C9H9N3O2 | 444731-73-1 | Details |
| Palonosetron Impurity 8 (Palonosetron N-Oxide) (Palonosetron USP Related Compound A) | C19H24N2O2 | 813425-83-1 | Details |
| Paracetamol Impurity 3（Paracetamol EP Impurity C） | C8H8ClNO2 | 3964-54-3 | Details |
| Parecoxib Impurity 3 | C22H23N3O7S2 | 1708094-99-8 | Details |
| Pazopanib Impurity 24 | C8H10N2O2 | 59816-94-3 | Details |
| Parecoxib Impurity 43 | C16H14N2O3S | 181695-84-1 | Details |
| Paracetamol Impurity 9（Paracetamol EP Impurity I） | C8H8O2 | 118-93-4 | Details |
| Parecoxib Impurity 45 | C16H14N2O3S | 2304623-37-6 | Details |
| Paracetamol Impurity 12(Paracetamol EP Impurity L) | C16H16N2O4 | 2514961-29-4 | Details |
| Paracetamol Impurity 45 | C8H8ClNO | 579-11-3 | Details |
| Paracetamol Impurity 8（Paracetamol EP Impurity H） | C10H11NO3 | 2623-33-8 | Details |
| Parecoxib Impurity 6 | C16H14N2O3S | 386273-25-2 | Details |
| Parecoxib Impurity 63 | C14H13NO | 57736-10-4 | Details |
| Paracetamol Impurity 14（Paracetamol EP Impurity N） | C16H16N2O3 | 3070-86-8 | Details |
| Paracetamol Impurity 4（Paracetamol EP Impurity D） | C8H9NO | 103-84-4 | Details |
| Parecoxib Impurity 29 | C19H18N2O4S | 2235371-89-6 | Details |
| Parecoxib Impurity 5 | C19H18N2O4S | 2229657-81-0 | Details |
| Palonosetron Impurity 9 | Details |
| Pazopanib Impurity 40 | C21H23N7O3S | 1821666-74-3 | Details |
| Parecoxib Impurity 14 | C7H10N2 | 1122-58-3 | Details |
| Parecoxib Impurity 84 | C16H14O3 | 108838-35-3 | Details |
| Product Total： Product Page： | ||||
| 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||